Biosimilars Adoption In Europe, US: Some Wins, 'Incomplete' Policies

 
• By Anju Ghangurde

Industry chiefs and experts, including Sandoz' global head of biopharmaceuticals, deliberated at the recent AAM meeting the status of biosimilars adoption in Europe and trends and opportunities to generate savings for both the US federal government and payers.

US EU Flags Gears Europe
Experts Share Insights On Uptake Of Biosimilars In Europe, US • Source: Shutterstock

More from Biosimilars

More from Products